Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

Alexander Bukreyev, Zhuhui Huang, Lijuan Yang, Subbiah Elankumaran, Marisa St. Claire, Brian R. Murphy, Siba K. Samal, Peter L. Collins

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Paramyxoviruses such as human parainfluenza viruses that bear inserts encoding protective antigens of heterologous viruses can induce an effective immunity against the heterologous viruses in experimental animals. However, vectors based on common human pathogens would be expected to be restricted in replication in the adult human population due to high seroprevalence, an effect that would reduce vector immunogenicity. To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus that is serotypically distinct from common human pathogens, as a vaccine vector. Two strains were evaluated: the attenuated vaccine strain LaSota (NDV-LS) that replicates mostly in the chicken respiratory tract and the Beaudette C (NDV-BC) strain of intermediate virulence that produces mild systemic infection in chickens. A recombinant version of each virus was modified by the insertion, between the P and M genes, of a gene cassette encoding the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neuraminidase (HN) protein, a test antigen with considerable historic data. The recombinant viruses were administered to African green monkeys (NDV-BC and NDV-LS) and rhesus monkeys (NDV-BC only) by combined intranasal and intratracheal routes at a dose of 106.5 PFU per site, with a second equivalent dose administered 28 days later. Little or no virus shedding was detected in nose-throat swabs or tracheal lavages following immunization with either strain. In a separate experiment, direct examination of lung tissue confirmed a highly attenuated, restricted pattern of replication by parental NDV-BC. The serum antibody response to the foreign HN protein induced by the first immunization with either NDV vector was somewhat less than that observed following a wild-type HPIV3 infection; however, the titer following the second dose exceeded that observed with HPIV3 infection, even though HPIV3 replicates much more efficiently than NDV in these animals. NDV appears to be a promising vector for the development of vaccines for humans; one application would be in controlling localized outbreaks of emerging pathogens.

Original languageEnglish (US)
Pages (from-to)13275-13284
Number of pages10
JournalJournal of Virology
Volume79
Issue number21
DOIs
StatePublished - Nov 2005
Externally publishedYes

Fingerprint

Newcastle disease virus
Human parainfluenza virus 3
Viral Antigens
viral antigens
Primates
viruses
Paramyxoviridae Infections
Monkey Diseases
Viruses
sialidase
Hemagglutinins
Neuraminidase
hemagglutinins
pathogens
Heterologous Immunity
Chickens
Avulavirus
Immunization
immunization
Vaccines

ASJC Scopus subject areas

  • Immunology

Cite this

Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. / Bukreyev, Alexander; Huang, Zhuhui; Yang, Lijuan; Elankumaran, Subbiah; St. Claire, Marisa; Murphy, Brian R.; Samal, Siba K.; Collins, Peter L.

In: Journal of Virology, Vol. 79, No. 21, 11.2005, p. 13275-13284.

Research output: Contribution to journalArticle

Bukreyev, A, Huang, Z, Yang, L, Elankumaran, S, St. Claire, M, Murphy, BR, Samal, SK & Collins, PL 2005, 'Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates', Journal of Virology, vol. 79, no. 21, pp. 13275-13284. https://doi.org/10.1128/JVI.79.21.13275-13284.2005
Bukreyev, Alexander ; Huang, Zhuhui ; Yang, Lijuan ; Elankumaran, Subbiah ; St. Claire, Marisa ; Murphy, Brian R. ; Samal, Siba K. ; Collins, Peter L. / Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. In: Journal of Virology. 2005 ; Vol. 79, No. 21. pp. 13275-13284.
@article{fca5258aff4e41f6bedaaf89fc1c019e,
title = "Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates",
abstract = "Paramyxoviruses such as human parainfluenza viruses that bear inserts encoding protective antigens of heterologous viruses can induce an effective immunity against the heterologous viruses in experimental animals. However, vectors based on common human pathogens would be expected to be restricted in replication in the adult human population due to high seroprevalence, an effect that would reduce vector immunogenicity. To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus that is serotypically distinct from common human pathogens, as a vaccine vector. Two strains were evaluated: the attenuated vaccine strain LaSota (NDV-LS) that replicates mostly in the chicken respiratory tract and the Beaudette C (NDV-BC) strain of intermediate virulence that produces mild systemic infection in chickens. A recombinant version of each virus was modified by the insertion, between the P and M genes, of a gene cassette encoding the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neuraminidase (HN) protein, a test antigen with considerable historic data. The recombinant viruses were administered to African green monkeys (NDV-BC and NDV-LS) and rhesus monkeys (NDV-BC only) by combined intranasal and intratracheal routes at a dose of 106.5 PFU per site, with a second equivalent dose administered 28 days later. Little or no virus shedding was detected in nose-throat swabs or tracheal lavages following immunization with either strain. In a separate experiment, direct examination of lung tissue confirmed a highly attenuated, restricted pattern of replication by parental NDV-BC. The serum antibody response to the foreign HN protein induced by the first immunization with either NDV vector was somewhat less than that observed following a wild-type HPIV3 infection; however, the titer following the second dose exceeded that observed with HPIV3 infection, even though HPIV3 replicates much more efficiently than NDV in these animals. NDV appears to be a promising vector for the development of vaccines for humans; one application would be in controlling localized outbreaks of emerging pathogens.",
author = "Alexander Bukreyev and Zhuhui Huang and Lijuan Yang and Subbiah Elankumaran and {St. Claire}, Marisa and Murphy, {Brian R.} and Samal, {Siba K.} and Collins, {Peter L.}",
year = "2005",
month = "11",
doi = "10.1128/JVI.79.21.13275-13284.2005",
language = "English (US)",
volume = "79",
pages = "13275--13284",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "21",

}

TY - JOUR

T1 - Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

AU - Bukreyev, Alexander

AU - Huang, Zhuhui

AU - Yang, Lijuan

AU - Elankumaran, Subbiah

AU - St. Claire, Marisa

AU - Murphy, Brian R.

AU - Samal, Siba K.

AU - Collins, Peter L.

PY - 2005/11

Y1 - 2005/11

N2 - Paramyxoviruses such as human parainfluenza viruses that bear inserts encoding protective antigens of heterologous viruses can induce an effective immunity against the heterologous viruses in experimental animals. However, vectors based on common human pathogens would be expected to be restricted in replication in the adult human population due to high seroprevalence, an effect that would reduce vector immunogenicity. To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus that is serotypically distinct from common human pathogens, as a vaccine vector. Two strains were evaluated: the attenuated vaccine strain LaSota (NDV-LS) that replicates mostly in the chicken respiratory tract and the Beaudette C (NDV-BC) strain of intermediate virulence that produces mild systemic infection in chickens. A recombinant version of each virus was modified by the insertion, between the P and M genes, of a gene cassette encoding the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neuraminidase (HN) protein, a test antigen with considerable historic data. The recombinant viruses were administered to African green monkeys (NDV-BC and NDV-LS) and rhesus monkeys (NDV-BC only) by combined intranasal and intratracheal routes at a dose of 106.5 PFU per site, with a second equivalent dose administered 28 days later. Little or no virus shedding was detected in nose-throat swabs or tracheal lavages following immunization with either strain. In a separate experiment, direct examination of lung tissue confirmed a highly attenuated, restricted pattern of replication by parental NDV-BC. The serum antibody response to the foreign HN protein induced by the first immunization with either NDV vector was somewhat less than that observed following a wild-type HPIV3 infection; however, the titer following the second dose exceeded that observed with HPIV3 infection, even though HPIV3 replicates much more efficiently than NDV in these animals. NDV appears to be a promising vector for the development of vaccines for humans; one application would be in controlling localized outbreaks of emerging pathogens.

AB - Paramyxoviruses such as human parainfluenza viruses that bear inserts encoding protective antigens of heterologous viruses can induce an effective immunity against the heterologous viruses in experimental animals. However, vectors based on common human pathogens would be expected to be restricted in replication in the adult human population due to high seroprevalence, an effect that would reduce vector immunogenicity. To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus that is serotypically distinct from common human pathogens, as a vaccine vector. Two strains were evaluated: the attenuated vaccine strain LaSota (NDV-LS) that replicates mostly in the chicken respiratory tract and the Beaudette C (NDV-BC) strain of intermediate virulence that produces mild systemic infection in chickens. A recombinant version of each virus was modified by the insertion, between the P and M genes, of a gene cassette encoding the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neuraminidase (HN) protein, a test antigen with considerable historic data. The recombinant viruses were administered to African green monkeys (NDV-BC and NDV-LS) and rhesus monkeys (NDV-BC only) by combined intranasal and intratracheal routes at a dose of 106.5 PFU per site, with a second equivalent dose administered 28 days later. Little or no virus shedding was detected in nose-throat swabs or tracheal lavages following immunization with either strain. In a separate experiment, direct examination of lung tissue confirmed a highly attenuated, restricted pattern of replication by parental NDV-BC. The serum antibody response to the foreign HN protein induced by the first immunization with either NDV vector was somewhat less than that observed following a wild-type HPIV3 infection; however, the titer following the second dose exceeded that observed with HPIV3 infection, even though HPIV3 replicates much more efficiently than NDV in these animals. NDV appears to be a promising vector for the development of vaccines for humans; one application would be in controlling localized outbreaks of emerging pathogens.

UR - http://www.scopus.com/inward/record.url?scp=27144444664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144444664&partnerID=8YFLogxK

U2 - 10.1128/JVI.79.21.13275-13284.2005

DO - 10.1128/JVI.79.21.13275-13284.2005

M3 - Article

C2 - 16227250

AN - SCOPUS:27144444664

VL - 79

SP - 13275

EP - 13284

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 21

ER -